Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts

  • Tang, Na
  • Zhao, Yanxia
  • Feng, Ruopeng
  • Liu, Yinan
  • Wang, Shuling
  • Wei, Wanguo
  • Ding, Qiang
  • An, Michael
  • Wen, Jinhua
  • Li, Lingsong
Publication date
January 2014
Publisher
journal of cellular and molecular medicine
Journal
issn:1582-4934

Abstract

Lung fibrosis is characterized by vascular leakage and myofibroblast recruitment, and both phenomena are mediated by lysophosphatidic acid (LPA) via its type-1 receptor (LPA1). Following lung damage, the accumulated myofibroblasts activate and secrete excessive extracellular matrix (ECM), and form fibrotic foci. Studies have shown that bone marrow-derived cells are an important source of myofibroblasts in the fibrotic organ. However, the type of cells in the bone marrow contributing predominantly to the myofibroblasts and the involvement of LPA-LPA1 signalling in this is yet unclear. Using a bleomycin-induced mouse lung-fibrosis model with an enhanced green fluorescent protein (EGFP) transgenic mouse bone marrow replacement, we first demons...

Extracted data

We use cookies to provide a better user experience.